Business profile

Neurovascular Innovations Oy

Neurovascular Innovations Oy's registered office is Helsingfors. It is a limited company. The company was established on 2023-02-26. It operates in the industry of all other miscellaneous professional, scientific and technical activities n.e.c.. In its latest retained statement for 2025-12-31, revenue was €6,000 and operating profit was -€3,000.

Claim profileContact details
Business ID 3346169-8ValidUnclaimed company profile

Trusted core data

Public company details from the trade register.

Business ID
3346169-8
Sector
All other miscellaneous professional, scientific and technical activities n.e.c.
Municipality
Helsingfors
Company form
Limited company
Registration date
2023-02-26
Business ID registration date
2023-02-18
Business status
Valid
Profile ownership
Unclaimed company profile

Contact and location summary

Visiting address: Haartmaninkatu 1, 00290, Helsingfors

People and decision-makers

Rezai Jahromi BehnamToimitusjohtaja

About Neurovascular Innovations Oy

Financial position and key figures for the company.

Neurovascular Innovations Oy's location municipality is Helsingfors. It is a limited company. The company was established on 2023-02-26. It operates in the industry of all other miscellaneous professional, scientific and technical activities n.e.c.. In its latest retained statement for 2025-12-31, revenue was €6,000 and operating profit was -€3,000. The latest retained financial statement for 2025-12-31 shows revenue of €6,000 and profit for the financial year of -€3,436. Based on the latest retained statement, revenue growth was -73.9%, operating margin was -50.0%, and equity ratio was +100.0%.

Extended business activity

A longer directory- or registry-backed activity description that complements the short registry industry label.

Yrityksen toimialaan kuuluu; immateriaalioikeuksien hallinta ja tuotanto sekä muiden henkilöiden ja yhtiöiden konsultoinnit kuten raportit, innovaatiot ja koulutustoiminta. Yhtiö voi omistaa muiden yhtiöiden osakkeita sekä optioita ja myös hallinoida immateriaalioikeuksia. Yhtiön ala on lääketiede.

Financial highlights

Key figures from the latest financial period.

Latest financial period

2025-12-31

Imported periods0
PRH parsed0
Profile sourceEnriched source observation
Derived indicators
Revenue growth-73.9%
Operating margin-50.0%
Equity ratio100.0%
Balance-sheet contextLatest financial period
Revenue trend3 periods
€12,000
2023-12-31
€23,000
2024-12-31
€6,000
2025-12-31
Operating profit (loss) trend3 periods
€1,000
2023-12-31
€13,000
2024-12-31
-€3,000
2025-12-31
Profit (loss) for the financial year trend3 periods
€399
2023-12-31
€10,123
2024-12-31
-€3,436
2025-12-31
Assets trend3 periods
€499
2023-12-31
€14,000
2024-12-31
€1,000
2025-12-31

Financial ratios

Financial ratios based on financial statement data. Source: Rikastettu lähdehavainto.

Equity ratioGood
100/100 · Improving
100.0 %2024-12-31: 66.7 %
Current ratioWeak
0/100 · Declining
0.00x2024-12-31: 2.80x
Operating profit marginWeak
0/100 · Declining
-50.0 %2024-12-31: 56.5 %
Ratio history
Ratio2023-12-312024-12-312025-12-31
Equity ratio100.0 %66.7 %100.0 %
Current ratio0.00x2.80x0.00x
Operating profit margin8.3 %56.5 %-50.0 %

Registry status and identifiers

Current registry information and identifiers based on YTJ data.

YTJ statusValid
Trade RegisterRegistered
Business ID3346169-8
VAT IDFI33461698
EU IDFIFPRO.3346169-8
MunicipalityHelsingfors
Current registered entries
2023-02-18VAT-liable for business activity in Tax Administration (VAT Register)
2023-02-26Registered in Patent and Registration Office (Trade Register)
2023-02-27Registered in Tax Administration (Tax Administration)

Responsible people

Public role relationships materialized from source observations.

Rezai Jahromi BehnamToimitusjohtajaSources: 4 · Confidence: 78%
Rezai Jahromi BijanVarajäsenSources: 2 · Confidence: 78%
Rezai Jahromi BehnamVarsinainen jäsenSources: 2 · Confidence: 78%

Risk certificate

An open-data based company stability and risk signal.

BUSINESS.fi

BUSINESS.fi Luottoluokitus

Profile-specific risk signal based on open data

Automatic gradeNot a credit decision
B2
SatisfactoryNeurovascular Innovations Oy
Grade downgradedB1 → B2 · new analysis 2026-10-19
Model score53/100
Assessment confidenceHigh
Evidence qualityStrong financial evidenceFinancial data included
Financial trajectoryFinancial development has been volatile across multiple domains.
3 comparable periods
RevenueVolatile
ProfitabilityVolatile
SolvencyVolatile
LiquidityVolatile
Peer comparisonSame size nationallyDescriptive comparison – does not change the model score.
345 peers
Solvency98%
Better than 98% of peers
Profitability16%
Below 84% of peers
Liquidity23%
Below 77% of peers
Revenue growth8%
Below 92% of peers
Supporting factors
  • Strong equity ratio
  • Company context reduces the weight of an isolated financial signal
  • Active registered status
Risk factors to note
  • Weak current ratio
  • Negative profitability or net result
  • Sharp year-over-year revenue drop
Rating historyAutomatic assessment developmentChanges are derived from evidence differences between persisted automatic assessments.
2 assessments
B2
2026-10-1953/100 · v0.15
B1 → B2 · -8 points
  • Revenue: Not enough history → Volatile
  • Profitability: Not enough history → Volatile
  • Solvency: Not enough history → Volatile
B1
2026-10-1061/100 · v0.14
Oldest retained automatic assessment in this comparison
Automatic model gradeB2
Automatic model snapshot2026-10-19
Automatic model versionopen-risk-grade-v0.15
Financial data included

The grade can use open digital financial statement data together with registry signals.

Verify assessment

Risk context

When sufficient source-backed financial metrics are not available for a Tier 1 assessment, BUSINESS.fi shows registry, industry, and regional context.

Industry riskmedium
67/100

Industry context is medium based on normalized open statistical inputs.

Age and continuityNuori
35/100

The company has about 3 years of registry continuity.

Registry and status signalsSeurattava
70/100

Registry history, filing recency, and active register markings are still limited or mixed.

Events & news

Verified events and sourced external company news in one timeline.

Risk grade updatedRisk gradeEvidence verified
19 Oct 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B2.
Risk grade updatedRisk gradeEvidence verified
10 Oct 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B1.

Registry timeline

Trade register notifications shown on a timeline.

6 register eventsLatest event: 2026-03-30

Profile source and ownership

Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2026-03-30.

This company profile has not been claimed yet

Neurovascular Innovations Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.